Cargando…

Severe agitation in severe early-onset Alzheimer’s disease resolves with ECT

Dementia-related behavioral disturbances are mostly treated with antipsychotics; however, the observed beneficial effects are modest and the risk of serious adverse effects high. We report the case of a 57-year-old woman with severe early-onset Alzheimer’s disease and severe agitation, whom we treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aksay, Suna Su, Hausner, Lucrezia, Frölich, Lutz, Sartorius, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235491/ https://www.ncbi.nlm.nih.gov/pubmed/25419138 http://dx.doi.org/10.2147/NDT.S71008

Ejemplares similares

Krankheitsmodifizierende Therapieansätze bei Alzheimer-Krankheit
por: Frölich, Lutz, et al.
Publicado: (2021)

Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia
por: Aksay, Suna Su, et al.
Publicado: (2017)

Case report: a giant arachnoid cyst masking Alzheimer’s disease
por: Wahl, Anna-Sophia, et al.
Publicado: (2019)

Ketofol-Dexmedetomidine combination in ECT: A punch for depression and agitation
por: Shams, Tarek, et al.
Publicado: (2014)

Electric field distribution models in ECT research
por: Sartorius, Alexander
Publicado: (2022)

An Agitated Patient With COVID-19 Infection and Early-onset Alzheimer Disease
por: Sykora, Daniel, et al.
Publicado: (2022)

Delayed Onset and Prolonged ECT-Related Delirium
por: Hassamal, Sameer, et al.
Publicado: (2013)

CLINICAL PREDICTORS OF RESPONSE TO ECT IN SEVERE DEPRESSION
por: Agrawal, Arun Lata
Publicado: (2001)

Development of a Proxy-Free Objective Assessment Tool of Instrumental Activities of Daily Living in Mild Cognitive Impairment Using Smart Home Technologies
por: Jekel, Katrin, et al.
Publicado: (2016)

Promoting neuroplasticity and neuropsychological functioning in frailty through an app-based sensorimotor training: study protocol for a randomized trial
por: Beier, Florian, et al.
Publicado: (2021)

Sensory and motor correlates of frailty: dissociation between frailty phenotype and frailty index
por: Beier, Florian, et al.
Publicado: (2022)

Stress Cardiomyopathy in Association with Severe Agitation in Dementia
por: Amin, Hina, et al.
Publicado: (2019)

Separating Symptomatic Alzheimer’s Disease from Depression based on Structural MRI
por: Klöppel, Stefan, et al.
Publicado: (2018)

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
por: Brinkmalm, Ann, et al.
Publicado: (2014)

24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer’s Disease: Analyses from a Clinical Trial with Nabilone
por: Ruthirakuhan, Myuri, et al.
Publicado: (2019)

Aripriprazole induced severe oculogyric dystonia treated with electroconvulsive therapy(ECT)
por: Bhat Shah, K., et al.
Publicado: (2023)

Agitated Saline Contrast Injection in Patients with Severe Hypoxemia
por: Millington, Scott J., et al.
Publicado: (2023)

Comparison of Visual Evoked Potentials and Retinal Nerve Fiber Layer Thickness in Alzheimer’s Disease
por: Kromer, Robert, et al.
Publicado: (2013)

Does ECT Work? the Impact of ECT on Depression
por: Collins, Dawn
Publicado: (2023)

Severe Agitation as an Unusual Presentation of Multisystem Inflammatory Syndrome in Children
por: Ghamry, Mohamed A, et al.
Publicado: (2022)

Theca lutein cysts and early onset severe preeclampsia
por: Sargin, Mehmet Akif, et al.
Publicado: (2016)

Efalizumab-induced severe thrombocytopenia can be resolved
por: Prignano, Francesca, et al.
Publicado: (2008)

THE PRACTICE OF ECT IN INDIA: II. THE PRACTICAL ADMINISTRATION OF ECT
por: Andrade, Chittaranjan, et al.
Publicado: (1993)

Catatonia, Pregnancy, and Electroconvulsive Therapy (ECT)
por: Gandhi, Khushbu, et al.
Publicado: (2023)

Deuterated dextromethorphan/quinidine for agitation in Alzheimer's disease
por: Khoury, Rita
Publicado: (2021)

Tablet-based sensorimotor home-training system for amnestic mild cognitive impairments in the elderly: design of a randomised clinical trial
por: Bekrater-Bodmann, Robin, et al.
Publicado: (2019)

REEVALUATION OF ECT
por: Abhyankar, Ravi
Publicado: (1985)

ECT Transport
por: Serge Pelletier, et al.
Publicado: (2007)

Empirical ratio of the combined use of S-ketamine and propofol in electroconvulsive therapy and its impact on seizure quality
por: Sartorius, Alexander, et al.
Publicado: (2020)

Effectiveness of Bifrontal ECT in Practice: A Comparison with Bitemporal ECT
por: Viswanath, Biju, et al.
Publicado: (2011)

THE PRACTICE OF ECT IN INDIA : ISSUES RELATING YO THE ADMINISTRATION OF ECT
por: Agarwal, A.K., et al.
Publicado: (1992)

SEIZURE DURATION OVER ECT SESSIONS: INFLUENCE OF SPACING ECTS
por: Janakiramaiah, N., et al.
Publicado: (1992)

A review of ketamine’s role in ECT and non-ECT settings
por: Jankauskas, Vytautas, et al.
Publicado: (2018)

ECT9 condensates with ECT1 and regulates plant immunity
por: Wang, Hui, et al.
Publicado: (2023)

Detection of Retinal Nerve Fiber Layer Defects in Alzheimer’s Disease Using SD-OCT
por: Kromer, Robert, et al.
Publicado: (2014)

Agitation in Alzheimer's disease: Novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria
por: De Mauleon, Adelaide, et al.
Publicado: (2021)

ECT IN MENTALLY RETARDED SUBJECTS WITH PSYCHIATRIC ILLNESS
por: Chopra, V.K, et al.
Publicado: (2002)

Patient with frontal-variant syndrome in early-onset Alzheimer's disease
por: Cai, Han, et al.
Publicado: (2020)

Institutionalization risk and costs associated with agitation in Alzheimer's disease
por: Cloutier, Martin, et al.
Publicado: (2019)

Suicidal ideation and ECT, ECT and suicidal ideation: A register study
por: Sienaert, Pascal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ed3ickmsrkpf5shso03ht59brs